Shares of 4D Molecular Therapeutics can more than double as it revolutionizes gene therapy treatment, according to BMO Capital Markets.
You are here: Home / BMO says this stock taking gene therapy to the ‘next level’ can more than double
Market News and Views
Shares of 4D Molecular Therapeutics can more than double as it revolutionizes gene therapy treatment, according to BMO Capital Markets.